ZA968550B - Novel processes for the preparation of anti-malarial compounds. - Google Patents

Novel processes for the preparation of anti-malarial compounds.

Info

Publication number
ZA968550B
ZA968550B ZA9608550A ZA968550A ZA968550B ZA 968550 B ZA968550 B ZA 968550B ZA 9608550 A ZA9608550 A ZA 9608550A ZA 968550 A ZA968550 A ZA 968550A ZA 968550 B ZA968550 B ZA 968550B
Authority
ZA
South Africa
Prior art keywords
preparation
novel processes
malarial compounds
malarial
compounds
Prior art date
Application number
ZA9608550A
Other languages
English (en)
Inventor
Cletus Onwuzurike Ugwuegbulam
James Edward Foy
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc
Publication of ZA968550B publication Critical patent/ZA968550B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9608550A 1995-10-13 1996-10-10 Novel processes for the preparation of anti-malarial compounds. ZA968550B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9521004.3A GB9521004D0 (en) 1995-10-13 1995-10-13 Process

Publications (1)

Publication Number Publication Date
ZA968550B true ZA968550B (en) 1998-04-14

Family

ID=10782264

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9608550A ZA968550B (en) 1995-10-13 1996-10-10 Novel processes for the preparation of anti-malarial compounds.

Country Status (27)

Country Link
US (1) US6479660B1 (pl)
EP (1) EP0871616B1 (pl)
JP (1) JP4083803B2 (pl)
KR (1) KR100453256B1 (pl)
CN (1) CN1147475C (pl)
AR (1) AR004015A1 (pl)
AT (1) ATE214372T1 (pl)
AU (1) AU709333B2 (pl)
BR (1) BR9611010A (pl)
CA (1) CA2231633C (pl)
CZ (1) CZ290380B6 (pl)
DE (1) DE69619863T2 (pl)
DK (1) DK0871616T3 (pl)
ES (1) ES2170874T3 (pl)
GB (1) GB9521004D0 (pl)
HU (1) HUP9900739A3 (pl)
IL (1) IL124060A (pl)
NO (1) NO313285B1 (pl)
NZ (1) NZ320209A (pl)
PL (1) PL186055B1 (pl)
PT (1) PT871616E (pl)
SA (1) SA97170574B1 (pl)
SI (1) SI0871616T1 (pl)
TR (1) TR199800637T2 (pl)
TW (1) TW450950B (pl)
WO (1) WO1997013753A1 (pl)
ZA (1) ZA968550B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08276712A (ja) * 1995-04-05 1996-10-22 Masao Tsuji チュ−ブレススパイクタイヤ
GB0210150D0 (en) * 2002-05-03 2002-06-12 Smithkline Beecham Plc Process
JP2009507824A (ja) * 2005-09-12 2009-02-26 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ 抗マラリアベイリス−ヒルマン付加物およびその調製方法
WO2007127930A2 (en) * 2006-04-28 2007-11-08 Kansas State University Research Foundation Compounds affecting gap junction activity
GB0620005D0 (en) 2006-10-10 2006-11-22 Glaxo Group Ltd Compounds
US20090076072A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched tafenoquine
ES2453206B1 (es) 2013-09-25 2015-01-12 Thyssenkrupp Elevator Innovation Center, S.A. Sistema de tracción para un sistema de transporte
CN113248431A (zh) * 2021-05-21 2021-08-13 重庆医药高等专科学校 一种磷酸伯氨喹的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US4617394A (en) * 1985-10-15 1986-10-14 The United States Of America As Represented By The Secretary Of The Army 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines

Also Published As

Publication number Publication date
TW450950B (en) 2001-08-21
SI0871616T1 (en) 2002-12-31
CN1147475C (zh) 2004-04-28
IL124060A (en) 2003-07-31
DE69619863T2 (de) 2002-11-21
AR004015A1 (es) 1998-09-30
TR199800637T2 (xx) 1998-07-21
DK0871616T3 (da) 2002-07-01
BR9611010A (pt) 1999-07-13
PL326194A1 (en) 1998-08-31
PT871616E (pt) 2002-07-31
SA97170574B1 (ar) 2006-09-25
GB9521004D0 (en) 1995-12-13
DE69619863D1 (de) 2002-04-18
CA2231633A1 (en) 1997-04-17
KR19990064210A (ko) 1999-07-26
HUP9900739A2 (hu) 1999-09-28
US6479660B1 (en) 2002-11-12
ATE214372T1 (de) 2002-03-15
WO1997013753A1 (en) 1997-04-17
CZ110398A3 (cs) 1998-09-16
NO313285B1 (no) 2002-09-09
CN1199395A (zh) 1998-11-18
EP0871616A1 (en) 1998-10-21
CA2231633C (en) 2006-10-03
HUP9900739A3 (en) 1999-11-29
NZ320209A (en) 1999-08-30
NO981537D0 (no) 1998-04-03
AU7291096A (en) 1997-04-30
NO981537L (no) 1998-04-03
CZ290380B6 (cs) 2002-07-17
AU709333B2 (en) 1999-08-26
JPH11513399A (ja) 1999-11-16
KR100453256B1 (ko) 2004-12-17
JP4083803B2 (ja) 2008-04-30
PL186055B1 (pl) 2003-09-30
HK1016180A1 (en) 1999-10-29
ES2170874T3 (es) 2002-08-16
EP0871616B1 (en) 2002-03-13

Similar Documents

Publication Publication Date Title
ZA968957B (en) Process for the preparation of dihaloazolopyrimidines.
ZA964624B (en) Process for the preparation of microcapsule compositions.
IL117188A0 (en) Process for the preparation of thietanones
ZA9710322B (en) Process for the preparation of benzyl-ethers.
AU1230595A (en) Process for the preparation of polyalkyl-1-oxa- diazaspirodecane compounds
IL133140A0 (en) Novel process for the preparation of 4-aryl-piperidines
EP0597329A3 (de) Verfahren zur Herstellung von alpha-Fluor -beta-dicarbonylverbindungen.
IL118200A0 (en) Process for the preparation of substituted 2-fluoro-pyrimidines
ZA963132B (en) Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine.
AU3731595A (en) Improved process for the preparation of 5-aminotetrazole
SI0871616T1 (en) Process for the preparation of anti-malarial drugs
HUP0003452A3 (en) Process for the preparation of 1-aryl-3-cyclopropyl-1,3-propanediones
AU5486396A (en) Process for the preparation of spiroindolines
ZA982255B (en) Process for the preparation of arylmalonates.
EP0635482A3 (de) Verfahren zur Herstellung von mehrfach fluorierten Nitrobenzolen.
ZA966452B (en) Process for the preparation of substituted aminocarbonyltriazolinones.
IL115090A0 (en) Process for the preparation of p-bromofluorobenzene
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
GR3024856T3 (en) Process for the preparation of dichloroacetylchloride.
EP0621264A3 (de) Verfahren zur Herstellung von 4-Alkanoaryl-benzylethern.
EP0635481A3 (de) Verfahren zur Herstellung von Fluornitrobenzolen.
EP0635486A3 (de) Verfahren zur Herstellung von Fluorbenzonitrilen.
IL118747A0 (en) Process for the preparation of 3-hydroxyoxetanes
EP0641764A3 (de) Verfahren zur Herstellung von Hydroxyalkylaminonitrobenzol-Derivaten.
IL118731A0 (en) Process for the preparation of 2,2-dialkyl-arylidene-cycloalkanones